查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1606431

連續血糖監測市場，按組件類型、按方式、按產品類型、按患者類型、按配銷通路、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Continuous Glucose Monitoring Market, By Component Type, By Modality, By Product Type, By Patient Type, By Distribution Channel, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年，連續血糖監測市場規模為 113.2932 億美元，2024 年至 2032 年複合年成長率為 12.79%。

連續血糖監測市場-市場動態

非侵入性血糖監測技術提供了更舒適、方便的替代方案。

非侵入性血糖監測技術正在蓬勃發展，因為它們有可能為傳統指尖採血測試提供更舒適、更方便的替代方案。連續血糖監測市場的主要驅動力包括生物感測器技術的進步，該技術無需皮膚穿透即可實現更準確、更可靠的測量。非侵入性方法，例如透過汗水、眼淚或紅外線進行監測，可以減少不適和感染風險，這對需要頻繁監測的患者很有吸引力。此外，糖尿病患者和醫療保健提供者對無痛、方便用戶使用型設備的日益青睞也推動了其採用。

非侵入性技術還有望擴大血糖監測對更廣泛用戶的吸引力，包括那些有糖尿病風險的用戶。這些系統的便利性可以提高患者的依從性並加強整體疾病管理。根據美國國立衛生研究院 (NIH) 的數據，估計有三分之一的美國成年人面臨糖尿病的風險，這進一步推動了對更方便、侵入性更小的監測解決方案的需求。隨著政府和學術界對非侵入性技術的支持不斷增加，隨著研究人員探索更多創新的糖尿病管理解決方案，市場有望成長。

連續血糖監測市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 12.79% 左右的複合年成長率成長

根據組件類型細分，感測器是 2023 年的領先細分市場

根據模態細分，侵入性是 2023 年的領先細分市場

根據產品類型細分，連續血糖監測系統 (CGMS) 預計將在 2023 年顯示最大的市場佔有率

根據患者類型細分，1 型糖尿病是 2023 年的主要細分市場

根據配銷通路細分，零售銷售是 2023 年的領先細分市場

按地區分類，北美是 2023 年的主要收入來源

連續血糖監測市場-細分分析：

全球連續血糖監測市場根據組件類型、模式、產品類型、患者類型、配銷通路和地區進行細分。

根據產品類型，市場分為兩類：連續血糖監測系統（CGMS）和自我監測血糖系統（SMBG）。在連續血糖監測系統 (CGMS) 市場中，主導部分是穿戴式 CGMS，特別是基於感測器的裝置。這些系統提供即時、連續的血糖資料，為糖尿病患者，尤其是第 1 型糖尿病患者帶來顯著益處。對更準確、方便用戶使用和微創解決方案不斷成長的需求推動了穿戴式式 CGMS 的採用，它可以與智慧型手機或胰島素幫浦整合，以實現自動資料追蹤和管理。該技術不僅提高了患者的便利性，還改善了血糖控制，使其成為市場成長的關鍵驅動力。

市場依模式分為兩類：侵入式 CGM 和非侵入式 CGM。侵入性連續血糖監測 (CGM) 系統是市場上最主要的部分。這些系統涉及皮下感測器，可連續即時監測血糖水平，提供準確可靠的資料。它們提供關鍵功能，例如低血糖或高血糖警報，以及與胰島素幫浦和智慧型手機的整合。侵入式 CGM 的主導地位歸功於其經過驗證的準確性、廣泛的監管批准以及領先製造商的強大市場影響力。儘管非侵入性系統不斷發展，但侵入性 CGM 仍然是有效管理糖尿病的首選。

連續血糖監測市場 - 地理洞察

由於糖尿病發病率上升以及人們對血糖管理重要性的認知不斷提高，北美連續血糖監測 (CGM) 市場的格局正在迅速擴大。美國佔據最大佔有率，1 型和 2 型糖尿病患者擴大採用 CGM 系統，因為它們能夠提供即時資料、改善血糖控制並減少併發症。技術的進步，例如更小、更便宜和方便用戶使用的設備，也推動了市場的成長。 CGM 裝置與行動應用程式和其他數位健康解決方案的整合進一步增強了它們的吸引力。此外，糖尿病相關併發症的日益流行，加上預防性醫療保健的推動，對 CGM 系統產生了強勁的需求。 FDA 等機構的監管批准和有利的報銷政策正在進一步加速採用。由於醫療保健系統優先考慮慢性病管理和個人化醫療，預計美國和加拿大的市場將持續成長。

連續血糖監測市場-競爭格局：

連續血糖監測 (CGM) 市場競爭格局的特點是既有成熟企業，也有專注於創新糖尿病管理解決方案的新興公司。 Abbott、Dexcom 和 Medtronic 等領先公司憑藉其先進的 CGM 系統佔據市場主導地位，這些系統提供即時血糖監測、與胰島素幫浦整合以及行動應用程式連接。 Abbott 的 FreeStyle Libre 和 Dexcom 的 G6/G7 系統是使用最廣泛的系統之一。美敦力也憑藉其 Guardian Connect 系統保持了強勢地位。像 Senseonics 這樣的新進業者及其植入式 Eversense CGM，為市場帶來了獨特的解決方案，提供更長的感測器壽命。該市場競爭激烈，各公司在感測器準確性、易用性、定價和患者資料管理能力等因素上競爭。 CGM 製造商與胰島素提供者或行動健康應用程式等製藥或科技公司之間的合作進一步加劇了競爭，推動了市場的創新和成長。此外，監管批准和報銷政策對於塑造競爭動態至關重要。

最新進展：

2024 年 2 月，Dexcom, Inc. 推出了最新的連續血糖監測 (CGM) Dexcom ONE+，以加強為比利時、西班牙和波蘭患者提供強大的新型糖尿病護理技術。

2024 年 1 月，雅培 (Abbott) 和胰島素輸送和糖尿病技術領域的 Tandem Diabetes Care, Inc. 推出了採用 Control-IQ 技術的 t: slim X2 胰島素泵，使其成為美國首個將使用FreeStyle Libre 2 Plus感應器.這使該組織能夠加強其產品組合。

2024 年1 月，美敦力(Medtronic) 的MiniMed 780G 系統獲得了CE 批准，該系統配備Simplera Sync，這是一種一次性一體式連續血糖監測儀(CGM)，不需要指尖採血或膠帶，以加強其產品線。帶來

目錄

第1章：連續血糖監測市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按組件類型分類的連續血糖監測市場片段
    • 按模式分類的連續血糖監測市場片段
    • 按產品類型分類的連續血糖監測市場片段
    • 按患者類型分類的連續血糖監測市場片段
    • 按配銷通路分類的連續血糖監測市場片段
    • 按國家/地區分類的連續血糖監測市場片段
    • 按地區分類的連續血糖監測市場片段
  • 競爭洞察

第 3 章：連續血糖監測主要市場趨勢

  • 連續血糖監測市場促進因素
    • 市場促進因素的影響分析
  • 連續血糖監測市場限制
    • 市場限制影響分析
  • 連續血糖監測市場機會
  • 連續血糖監測市場未來趨勢

第 4 章：連續血糖監測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：連續血糖監測市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：連續血糖監測市場格局

  • 2023 年連續血糖監測市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：連續血糖監測市場 - 依組件類型

  • 概述
    • 按組件類型分類的細分市場佔有率分析
    • 發射器和接收器
    • 感應器

第 8 章：連續血糖監測市場 - 按模式

  • 概述
    • 按方式分類的細分市場佔有率分析
    • 非侵入性
    • 侵入性

第 9 章：連續血糖監測市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
      • 自我監測血糖 (SMBG) 系統
      • 連續血糖監測 (CBGM) 系統

第 10 章：連續血糖監測市場 - 依病患類型

  • 概述
    • 按患者類型分類的細分市場佔有率分析
    • 1 型糖尿病
    • 2 型糖尿病

第 11 章：連續血糖監測市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 機構銷售
    • 零售銷售
    • 其他

第 12 章：連續血糖監測市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美連續血糖監測主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按組件類型）
    • 北美市場規模和預測（按方式）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按患者類型）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲連續血糖監測主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按組件類型）
    • 歐洲市場規模與預測（按方式）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按患者類型）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區連續血糖監測主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按組件類型）
    • 亞太地區市場規模與預測（按方式）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模和預測（按患者類型）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲連續血糖監測主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按組件類型）
    • 拉丁美洲市場規模與預測（按方式）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按患者類型）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲連續血糖監測主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按組件類型）
    • 中東和非洲市場規模及預測（按方式）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按患者類型）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 13 章：主要供應商分析 - 連續血糖監測產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Dexcom, Inc.
    • Medtronic plc
    • Senseonics Holdings, Inc.
    • Roche Diagnostics
    • LifeScan, Inc.
    • Ascensia Diabetes Care
    • Tandem Diabetes Care, Inc.
    • Insulet Corporation
    • Ypsomed Holding AG
    • Johnson & Johnson
    • GlucoWise
    • Beta Bionics
    • Pear Therapeutics
    • Diasend
    • F. Hoffmann-La Roche AG
    • Novo Nordisk A/S
    • Glooko, Inc.

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4256

REPORT HIGHLIGHT

Continuous Glucose Monitoring Market size was valued at USD 11,329.32 Million in 2023, expanding at a CAGR of 12.79% from 2024 to 2032.

The Continuous Glucose Monitoring (CGM) market refers to the sector that develops and supplies devices designed to track glucose levels in real-time throughout the day and night. These devices are primarily used by individuals with diabetes to manage their blood sugar levels more effectively, reducing the need for frequent fingerstick testing. CGMs work by using a sensor placed under the skin to measure glucose in the interstitial fluid, transmitting data to a receiver or smartphone. The market has seen significant growth due to rising diabetes prevalence, increasing awareness about diabetes management, and technological advancements that have made CGMs more accurate, affordable, and user-friendly. CGMs also offer features like alerts for hypo- or hyperglycemia and integration with insulin pumps, providing enhanced control. As healthcare systems emphasize preventative care, the demand for CGMs is expected to continue rising, creating opportunities for innovation and expansion in the market.

Continuous Glucose Monitoring Market- Market Dynamics

Non-invasive glucose monitoring technologies offer more comfortable, convenient alternatives.

Non-invasive glucose monitoring technologies are gaining momentum due to their potential to offer more comfortable, convenient alternatives to traditional fingerstick testing. Key drivers for the Continuous Glucose Monitoring Market include advancements in biosensor technology, which are enabling more accurate and reliable measurements without the need for skin penetration. Non-invasive methods, such as monitoring through sweat, tears, or infrared light, reduce discomfort and the risk of infection, which appeals to patients who require frequent monitoring. Furthermore, the growing preference for painless, user-friendly devices among diabetic patients and healthcare providers is fueling adoption.

Non-invasive technologies also promise to broaden the appeal of glucose monitoring to a wider range of users, including those at risk of developing diabetes. The convenience of these systems can improve patient compliance and enhance overall disease management. According to the National Institutes of Health (NIH), an estimated 1 in 3 American adults is at risk of developing diabetes, further driving the demand for more accessible and less invasive monitoring solutions. With increasing government and academic support for non-invasive technologies, the market is poised for growth as researchers explore more innovative solutions for diabetes management.

Continuous Glucose Monitoring Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.79% over the forecast period (2024-2032)

Based on Component Type segmentation, Sensors was the leading segment in 2023

Based on Modality segmentation, Invasive was the leading segment in 2023

Based on Product Type segmentation, Continuous Glucose Monitoring Systems (CGMS) was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Type 1 diabetes was the leading segment in 2023

Based on Distribution Channel segmentation, Retail Sales was the leading segment in 2023

based on Region, North America was the leading revenue generator in 2023

Continuous Glucose Monitoring Market- Segmentation Analysis:

The Global Continuous Glucose Monitoring Market is segmented based on Component Type, Modality, Product Type, Patient Type, Distribution Channel, and Region.

The market is divided into two categories based on Product Type: Continuous Glucose Monitoring Systems (CGMS) and Self-Monitoring Blood Glucose Systems (SMBG). In the Continuous Glucose Monitoring Systems (CGMS) market, the dominant segment is the wearable CGMS, particularly the sensor-based devices. These systems provide real-time, continuous glucose data, offering significant benefits for patients with diabetes, especially those with Type 1 diabetes. The growing demand for more accurate, user-friendly, and minimally invasive solutions has driven the adoption of wearable CGMS, which can be integrated with smartphones or insulin pumps for automated data tracking and management. This technology not only enhances patient convenience but also improves glycemic control, making it a key driver in the market's growth.

The market is divided into two categories based on Modality: Invasive CGM and Non-Invasive CGM. Invasive Continuous Glucose Monitoring (CGM) systems are the most dominant segment in the market. These systems involve a subcutaneous sensor that continuously monitors glucose levels in real time, providing accurate and reliable data. They offer key features such as alerts for hypo- or hyperglycemia, and integration with insulin pumps and smartphones. The dominance of invasive CGMs is due to their proven accuracy, extensive regulatory approvals, and strong market presence from leading manufacturers. Despite the ongoing development of non-invasive systems, invasive CGMs remain the preferred choice for managing diabetes effectively.

Continuous Glucose Monitoring Market- Geographical Insights

The North American landscape for the Continuous Glucose Monitoring (CGM) market is rapidly expanding, driven by rising incidences of diabetes and increasing awareness about the importance of glucose management. The U.S. holds the largest share, with both Type 1 and Type 2 diabetes patients increasingly adopting CGM systems due to their ability to provide real-time data, improve glycemic control, and reduce complications. Advancements in technology, such as smaller, more affordable, and user-friendly devices, are also fueling market growth. The integration of CGM devices with mobile apps and other digital health solutions is further enhancing their appeal. Moreover, the growing prevalence of diabetes-related complications, coupled with the push for preventive healthcare, is creating a strong demand for CGM systems. Regulatory approvals from bodies like the FDA and favorable reimbursement policies are further accelerating adoption. As healthcare systems prioritize chronic disease management and personalized medicine, the market is expected to see continued growth in both the U.S. and Canada.

Continuous Glucose Monitoring Market- Competitive Landscape:

The competitive landscape of the Continuous Glucose Monitoring (CGM) market is characterized by a mix of established players and emerging companies focused on innovative diabetes management solutions. Leading companies like Abbott, Dexcom, and Medtronic dominate the market, with their advanced CGM systems offering real-time glucose monitoring, integration with insulin pumps, and mobile app connectivity. Abbott's FreeStyle Libre and Dexcom's G6/G7 systems are among the most widely used. Medtronic also maintains a strong position with its Guardian Connect system. Newer entrants like Senseonics, with its implantable Eversense CGM, bring unique solutions to the market, offering longer sensor life. The market is highly competitive with companies competing on factors like sensor accuracy, ease of use, pricing, and patient data management capabilities. Partnerships between CGM manufacturers and pharmaceutical or tech companies, such as insulin providers or mobile health apps, further intensify competition, driving innovation and growth in the market. Furthermore, regulatory approval and reimbursement policies are crucial in shaping the competitive dynamics.

Recent Developments:

In February 2024, Dexcom, Inc. introduces Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), to strengthen strong, new diabetes care technologies for patients in Belgium, Spain, and Poland.

In January 2024, Abbott and Tandem Diabetes Care, Inc., a player in insulin delivery and diabetes technologies, unveiled the t: slim X2 insulin pump with Control-IQ technology, making it the first automated insulin administration system in the United States to combine with the FreeStyle Libre 2 Plus sensor. This enabled the organization to strengthen its product portfolio.

In January 2024, Medtronic got CE approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one Continuous Glucose Monitor (CGM) that does not require fingersticks or overtape, to strengthen its product line. to bring

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Dexcom, Inc.
  • Medtronic plc
  • Senseonics Holdings, Inc.
  • Roche Diagnostics
  • LifeScan, Inc.
  • Ascensia Diabetes Care
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Ypsomed Holding AG
  • Johnson & Johnson
  • GlucoWise
  • Beta Bionics
  • Pear Therapeutics
  • Diasend
  • F. Hoffmann-La Roche AG
  • Novo Nordisk A/S
  • Glooko, Inc.

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Transmitters and Receivers
  • Sensors

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Non-invasive
  • Invasive

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Self-Monitoring Blood Glucose (SMBG) Systems
  • Continuous Blood Glucose Monitoring (CBGM) Systems

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type-1 Diabetes
  • Type-2 Diabetes

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Institutional Sales
  • Retail Sales
  • Others

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Glucose Monitoring Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Glucose Monitoring Market Snippet by Component Type
    • 2.1.2. Continuous Glucose Monitoring Market Snippet by Modality
    • 2.1.3. Continuous Glucose Monitoring Market Snippet by Product Type
    • 2.1.4. Continuous Glucose Monitoring Market Snippet by Patient Type
    • 2.1.5. Continuous Glucose Monitoring Market Snippet by Distribution Channel
    • 2.1.6. Continuous Glucose Monitoring Market Snippet by Country
    • 2.1.7. Continuous Glucose Monitoring Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Glucose Monitoring Key Market Trends

  • 3.1. Continuous Glucose Monitoring Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Glucose Monitoring Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Glucose Monitoring Market Opportunities
  • 3.4. Continuous Glucose Monitoring Market Future Trends

4. Continuous Glucose Monitoring Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Glucose Monitoring Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Continuous Glucose Monitoring Market Landscape

  • 6.1. Continuous Glucose Monitoring Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Glucose Monitoring Market - By Component Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
    • 7.1.2. Transmitters and Receivers
    • 7.1.3. Sensors

8. Continuous Glucose Monitoring Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 8.1.2. Non-invasive
    • 8.1.3. Invasive

9. Continuous Glucose Monitoring Market - By Product Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
      • 9.1.1.1. Self-Monitoring Blood Glucose (SMBG) Systems
      • 9.1.1.2. Continuous Blood Glucose Monitoring (CBGM) Systems

10. Continuous Glucose Monitoring Market - By Patient Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 10.1.2. Type-1 Diabetes
    • 10.1.3. Type-2 Diabetes

11. Continuous Glucose Monitoring Market - By Distribution Channel

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 11.1.2. Institutional Sales
    • 11.1.3. Retail Sales
    • 11.1.4. Others

12. Continuous Glucose Monitoring Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Continuous Glucose Monitoring Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.9. The U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Continuous Glucose Monitoring Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Continuous Glucose Monitoring Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Continuous Glucose Monitoring Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Continuous Glucose Monitoring Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Continuous Glucose Monitoring Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Dexcom, Inc.
    • 13.2.3. Medtronic plc
    • 13.2.4. Senseonics Holdings, Inc.
    • 13.2.5. Roche Diagnostics
    • 13.2.6. LifeScan, Inc.
    • 13.2.7. Ascensia Diabetes Care
    • 13.2.8. Tandem Diabetes Care, Inc.
    • 13.2.9. Insulet Corporation
    • 13.2.10. Ypsomed Holding AG
    • 13.2.11. Johnson & Johnson
    • 13.2.12. GlucoWise
    • 13.2.13. Beta Bionics
    • 13.2.14. Pear Therapeutics
    • 13.2.15. Diasend
    • 13.2.16. F. Hoffmann-La Roche AG
    • 13.2.17. Novo Nordisk A/S
    • 13.2.18. Glooko, Inc.

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us